Coreg and Electrocardiogram t wave inversion - a phase IV clinical study of FDA data

Summary:

Electrocardiogram t wave inversion is reported as a side effect among people who take Coreg (carvedilol), especially for people who are male, 60+ old, also take Aspirin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Electrocardiogram t wave inversion when taking Coreg. It is created by eHealthMe based on reports of 48,155 people who have side effects when taking Coreg from the FDA, and is updated regularly.

What is Coreg?

Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.

What is Electrocardiogram t wave inversion?

Electrocardiogram t wave inversion is found to be associated with 417 drugs and 761 conditions by eHealthMe. Check the latest studies of Electrocardiogram t wave inversion.

On Jul, 03, 2026

48,155 people reported to have side effects when taking Coreg.
Among them, 43 people (0.09%) have Electrocardiogram t wave inversion.

Could Coreg cause Electrocardiogram t wave inversion?

Among these 43 people:

What is the gender of people who have Electrocardiogram t wave inversion when taking Coreg? *

female: 25.58 %
male: 74.42 %

What is the age of people who have Electrocardiogram t wave inversion when taking Coreg? *

What are other drugs people take besides Coreg? *

What are other side effects people have besides Electrocardiogram t wave inversion? *

Mitral Valve Incompetence (inefficient heart valve): 23 people, 53.49%
Tricuspid Valve Incompetence (inefficient heart valve): 22 people, 51.16%
Cardiac Failure Congestive: 19 people, 44.19%
Dyspnea (difficult or laboured breathing): 18 people, 41.86%
Fatigue (feeling of tiredness): 17 people, 39.53%
Nausea (feeling of having an urge to vomit): 16 people, 37.21%
Dizziness: 16 people, 37.21%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 14 people, 32.56%
Chest Pain: 13 people, 30.23%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 13 people, 30.23%

What are the existing conditions these people have? *

High Blood Cholesterol: 4 people, 9.30%
Cardiac Failure Congestive: 3 people, 6.98%
Cardiac Disorder: 3 people, 6.98%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 4.65%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 4.65%
Pain: 1 person, 2.33%
Neuralgia (pain in one or more nerves): 1 person, 2.33%
Nausea (feeling of having an urge to vomit): 1 person, 2.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.33%
Heart Rate Irregular: 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Coreg and have Electrocardiogram t wave inversion?

- Check whether Electrocardiogram t wave inversion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Coreg:

Coreg (49,583 reports)

Browse all side effects of Coreg:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram t wave inversion:

Electrocardiogram t wave inversion (417 drugs)

Browse all the conditions that are associated with Electrocardiogram t wave inversion:

Electrocardiogram t wave inversion (761 conditions)

Related publications that referenced our studies

Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carvedilol (the active ingredients of Coreg) and Coreg (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.